Abstract: A solid antimicrobial hydrogel comprising a first amphiphilic component. The first amphiphilic component, in its chemically cross-linked state, being a lyotropic liquid crystal and having an ordered nanostructure of hydrophobic and hydrophilic domains, the composition further comprising an antimicrobial agent being covalently attached to at least one of the hydrophilic or hydrophobic domains.
Type:
Grant
Filed:
October 1, 2018
Date of Patent:
February 1, 2022
Assignee:
AMFERIA AB
Inventors:
Anand Kumar Rajasekharan, Saba Atefykta, Martin Andersson
Abstract: The present disclosure relates to elastomeric lyotropic liquid crystal (E-LLC) and mesoporous elastomers, wherein the mesoporous elastomer possesses a combination of covalent chemical crosslinks and physical chain entanglement crosslinks. The production and use such mesoporous elastomers is also provided.
Type:
Application
Filed:
April 8, 2019
Publication date:
July 22, 2021
Applicant:
AMFERIA AB
Inventors:
Anand Kumar RAJASEKHARAN, Martin ANDERSSON
Abstract: A solid antimicrobial hydrogel comprising a first amphiphilic component. The first amphiphilic component, in its chemically cross-linked state, being a lyotropic liquid crystal and having an ordered nanostructure of hydrophobic and hydrophilic domains, the composition further comprising an antimicrobial agent being covalently attached to at least one of the hydrophilic or hydrophobic domains.
Type:
Application
Filed:
October 1, 2018
Publication date:
July 30, 2020
Applicant:
AMFERIA AB
Inventors:
Anand Kumar RAJASEKHARAN, Saba ATEFYKTA, Martin ANDERSSEN